SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000882104-19-000054
Filing Date
2019-05-09
Accepted
2019-05-09 16:07:03
Documents
98
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q pdli-2019033110qdoc.htm 10-Q 1675988
2 2019 ANNUAL BONUS PLAN pdli-2019033110qex103.htm EX-10.3 15106
3 RATIO OF EARNINGS TO FIXED CHARGES pdli-2019033110qex121.htm EX-12.1 57926
4 CERTIFICATION pdli-2019033110qex311.htm EX-31.1 10975
5 CERTIFICATION pdli-2019033110qex312.htm EX-31.2 11259
6 CERTIFICATION pdli-2019033110qex321.htm EX-32.1 14289
13 pdllogoa17.jpg GRAPHIC 123123
  Complete submission text file 0000882104-19-000054.txt   11096476

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT pdli-20190331.xml EX-101.INS 2260803
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pdli-20190331.xsd EX-101.SCH 106801
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT pdli-20190331_cal.xml EX-101.CAL 124867
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pdli-20190331_def.xml EX-101.DEF 647967
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pdli-20190331_lab.xml EX-101.LAB 1080658
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pdli-20190331_pre.xml EX-101.PRE 819183
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19756 | Film No.: 19810539
SIC: 2836 Biological Products, (No Diagnostic Substances)